Pharma launches are among the most complex and high‑stakes operating challenges organizations take on. Despite significant investment, many launches underperform not because of the market alone, but due to fragmented planning, unclear governance, and inconsistent execution.
To address this, Launch Excellence (LX) brings strategy, governance, and execution together in a single operating model that establishes decision clarity early and holds teams together as pressure builds.
One of the earliest signals that execution may not hold is launch readiness itself.
Readiness is often assumed, then tested
Most organizations believe they are ready to launch. Plans are recycled, teams are pulled together from current structures, and timelines are built on optimistic assumptions. Readiness is often assumed rather than proven under launch conditions.
Early launch risk typically shows up in five areas:
- Process clarity: Is there a defined, repeatable launch process, or does execution rely on prior experience and individual judgment?
- Team readiness: Are teams resourced for the scale, speed, and complexity the launch will demand?
- Cross‑functional alignment: Are Sales, Marketing, Market Access, and Medical aligned on priorities and timing. And is data consistently informing decisions?
- Scenario planning: Have assumptions been pressure‑tested and are credible alternatives in place?
- Post‑launch sustainability: Is there a plan to maintain momentum beyond approval and early launch?
A “no” in any of the above is not a failure. It is a signal to regroup. These types of gaps are common, and they often determine whether teams maintain momentum or experience launch fatigue once pressure peaks.
What makes Launch Excellence different from traditional launch models?
Traditionally, launches have been managed through three parallel and often disconnected efforts:
- Prepping the brand through positioning, differentiation, and messaging
- Prepping the market through disease awareness, access, and external readiness
- Prepping the organization through operational readiness and internal capability
When these efforts run in siloes, misalignment grows, friction increases, and timelines slip. The impact is amplified in lean or fast-growing organizations where resources are constrained and leadership attention is divided.
This integration gap is exactly what Launch Excellence is designed to address.
What works is not more coordination, but better integration. Brand strategy, organizational readiness, and market preparation must advance in parallel, anchored to a shared operating model that clarifies priorities, decision rights, and timing.
Launch Excellence as an operating model
Launch Excellence integrates existing functional processes while adding structure, accountability, and clarity across the lifecycle. Its value lies in answering the questions that repeatedly slow or derail launches:
- How can execution be simplified without sacrificing rigor?
- How can organizations scale effectively with limited resources?
- What decisions require global alignment, and what should be made locally?
- Is planning centered around regulatory approval, first commercial sale, or both?
LX is not program management. It is a shared operating model and culture for launch success.
From readiness to results: Executing Launch Excellence
Building the foundation: Governance and planning (T-24 to T-18)
Strong launches begin well before execution accelerates. The foundation is strong governance that establishes clarity early and sustains it over time. This includes:
- Clear roles, decision rights, and escalation paths
- A core launch team across Marketing, Medical, Access, Supply, Regulatory, etc.
- Streamlined meetings with purpose and outcomes
- A governance model that balances speed and visibility
Effective core teams are enabled by practical mechanisms:
- Workstream charters with clear ownership
- Defined engagement between core teams and steering committee
- Consistent meeting cadence and decision logic
- Risk identification, mitigation, and escalation paths
Fit‑for‑purpose tools reinforce these behaviors. When tools shift focuses toward administration rather than risk and accountability, they slow teams down. Governance structures should simplify, not add administrative burdens.
Balancing complexity and internal dynamics (T-18 to T-12)
When nearing approval, team constraints intensify. Anticipate challenges such as:
- Leadership alignment with the launch strategy
- Multiple parallel launches
- Resource and funding constraints
Encourage honest status reporting. Green lights don’t always mean “on track.” Facilitate conversations that capture interdependencies, reveal gaps or bottlenecks, and enable early decisions.
Core team enablers:
- Transparent, actionable dashboards
- Flexible reporting formats
- Milestone deep dives
- Experienced launch leadership focused on removing roadblocks
Capturing momentum and readiness (T-12 to T-0+)
The year before launch is crunch time for the team. If assumptions haven’t been tested, gaps will quickly appear.
High-value activities include:
- Workstream readiness assessments
- Mock‑launch simulations for key scenarios
- Cross‑functional integration exercises
- KPI definitions and communication planning
- Market access and reimbursement readiness
Celebrate milestones and progress to maintain team engagement. By launch, the integrated plan should be operational and fully aligned.
Post‑launch sustainability (T-6+)
Launch planning does not end with regulatory approval, especially if product availability lags. Go-Live should be treated as a managed transition rather than a finish line.
Effective post‑launch practices include:
- Hypercare models for rapid issue resolution
- After‑action reviews (AARs) with documented learnings
- Ongoing monitoring of KPIs and adoption trends
- Continuous communication with stakeholders
- Feedback loops from field teams, patients, and partners
- Faster, clearer decision making
- Stronger alignment across brand, market, and operational plans
- Early risk identification and mitigation
- Resources focused on the high-value activities
- A repeatable capability that scales across the portfolio
A structured transition from the launch team to the broader organization helps preserve institutional knowledge. Captured insights should be folded back into an evolving LX playbook to strengthen future launches and indications.
What Launch Excellence enables
Organizations that adopt an LX framework can expect:
- Faster, clearer decision making
- Stronger alignment across brand, market, and operational plans
- Early risk identification and mitigation
- Resources focused on the high-value activities
- A repeatable capability that scales across the portfolio
Final thoughts
Launch Excellence is not a one-time initiative. It is a capability built through disciplined planning, aligned teams, and a unified operating model. As launch environments grow more complex, organizations that invest early and execute with clarity improve their ability to deliver on the promise of therapies.
Our Commercial Launch & Lifecycle Management team brings deep experience across dozens of launch partnerships. Contact us to explore how LX can be tailored to your organization.
